Literature DB >> 31690385

Allergic bronchopulmonary aspergillosis.

Gayatri Patel, Paul A Greenberger.   

Abstract

Allergic bronchopulmonary aspergillosis (ABPA) occurs in patients with asthma or cystic fibrosis, and results in pulmonary infiltrates, tenacious mucus plugs that harbor hyphae of Aspergillus fumigatus, elevations of total serum immunoglobulin E concentration and peripheral blood and sputum eosinophilia. Bronchiectasis is an irreversible complication of ABPA. The key to early diagnosis is to consider ABPA in anyone with asthma or cystic fibrosis and with a positive skin test result for Aspergillus, and/or recurrent infiltrates on radiographs. The differential diagnosis for ABPA in patients with asthma includes diseases in which there is an overlap of asthma, peripheral blood eosinophilia, and radiographic infiltrates. Examples include chronic eosinophilic pneumonia, Churg-Strauss syndrome, drug-induced pulmonary infiltrates, infection with a parasite, asthma with atelectasis, and lymphoma. Mucus plugging that causes a "tree in bud" pattern on computerized tomography examination of the lungs may be from ABPA or other conditions, such as nontuberculous (atypical) mycobacteria (Mycobacteria avium-Mycobacteria intracellulare complex). Prednisone is indicated to clear pulmonary infiltrates, and a usual course is for 3 months. Itraconazole and voriconazole are adjunctive, and drug-drug interactions must be considered because azoles decrease elimination of various medications. Although not familial in most patients, presentation of Aspergillus fumigatus f1 (Asp f1) antigen is restricted to specific major histocompatibility complex (MHC) class II molecules, Human Leukocyte Antigen-DR2 (HLA-DR2), and HLA-DR5. There is an increased number of CD4+ T-helper type 2 lymphocytes in bronchoalveolar lavage, and A. fumigatus can serve as a growth factor of eosinophils potentiating the effects of interleukin (IL) 3, IL-5, and Granulocyte-colony stimulating factor (G-CSF). Eosinophils interact directly with A. fumigatus spores and generate extracellular traps, which can injure the bronchial epithelium.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31690385     DOI: 10.2500/aap.2019.40.4262

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN: 1088-5412            Impact factor:   2.587


  9 in total

1.  Serum Cytokines Usefulness for Understanding the Pathology in Allergic Bronchopulmonary Aspergillosis and Chronic Pulmonary Aspergillosis.

Authors:  Yuya Ito; Takahiro Takazono; Yasushi Obase; Susumu Fukahori; Nobuyuki Ashizawa; Tatsuro Hirayama; Masato Tashiro; Kazuko Yamamoto; Yoshifumi Imamura; Naoki Hosogaya; Chizu Fukushima; Yoshitomo Morinaga; Katsunori Yanagihara; Koichi Izumikawa; Hiroshi Mukae
Journal:  J Fungi (Basel)       Date:  2022-04-23

Review 2.  The Conundrum of Lung Disease and Drug Hypersensitivity-like Reactions in Systemic Juvenile Idiopathic Arthritis.

Authors:  Bryce A Binstadt; Peter A Nigrovic
Journal:  Arthritis Rheumatol       Date:  2022-05-29       Impact factor: 15.483

3.  Allergic bronchopulmonary aspergillosis in association with rheumatic heart disease: report of three cases.

Authors:  Vikas Deep Goyal; Akhilesh Pahare; Gaurav Misra
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2022-08-01

4.  Value of CT Radiomics Combined with Clinical Features in the Diagnosis of Allergic Bronchopulmonary Aspergillosis.

Authors:  Xiaojun Qian; Hengmo Rong; Xue Wei; Guangsheng Rong; Mengxing Yao
Journal:  Comput Math Methods Med       Date:  2022-05-05       Impact factor: 2.809

Review 5.  Emerging Fungal Threats in Cystic Fibrosis.

Authors:  C Schwarz; P Eschenhagen; J P Bouchara
Journal:  Mycopathologia       Date:  2021-07-28       Impact factor: 2.574

6.  Suppression of Aspergillus fumigatus Germination by Neutrophils Is Enhanced by Endothelial-Derived CSF3 Production.

Authors:  Wenxin Zhang; Dan He; Yunyun Wei; Shumi Shang; Dong Li; Li Wang
Journal:  Front Microbiol       Date:  2022-04-29       Impact factor: 5.640

Review 7.  Approach to Eosinophilia Presenting With Pulmonary Symptoms.

Authors:  Chen E Rosenberg; Paneez Khoury
Journal:  Chest       Date:  2020-09-28       Impact factor: 9.410

Review 8.  Allergic Diseases Caused by Aspergillus Species in Patients with Cystic Fibrosis.

Authors:  Aidan K Curran; David L Hava
Journal:  Antibiotics (Basel)       Date:  2021-03-28

Review 9.  Mast Cell Modulation of B Cell Responses: An Under-Appreciated Partnership in Host Defence.

Authors:  Alejandro M Palma; Mark R Hanes; Jean S Marshall
Journal:  Front Immunol       Date:  2021-09-10       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.